Prevalence of Abnormal Liver Function Tests in Celiac Disease and the Effect of a Gluten-Free Diet in the US Population

2015 ◽  
Vol 110 (8) ◽  
pp. 1216-1222 ◽  
Author(s):  
Natalia E Castillo ◽  
Rohini R Vanga ◽  
Thimmaiah G Theethira ◽  
Alberto Rubio-Tapia ◽  
Joseph A Murray ◽  
...  
Keyword(s):  
Celiac Disease ◽  
Liver Function ◽  
Liver Function Tests ◽  
Abnormal Liver Function ◽  
Gluten Free Diet ◽  
Gluten Free ◽  
Function Tests ◽  
The Us

Alpha 1 Anti Trypsin Levels in Asymptomatic Patients with Abnormal Liver Function Tests

Endoscopy ◽  
2006 ◽  
Vol 38 (11) ◽  
Author(s):  
BJ Egan ◽  
S Sarwar ◽  
M Anwar ◽  
C O'Morain ◽  
B Ryan
Keyword(s):  
Liver Function ◽  
Liver Function Tests ◽  
Abnormal Liver Function ◽  
Function Tests ◽  
Asymptomatic Patients

scholarly journals Abnormal Liver Function Tests and Long-Term Outcomes in Patients Discharged after Acute Heart Failure

2021 ◽  
Vol 10 (8) ◽  
pp. 1730
Author(s):  
Hiroshi Miyama ◽  
Yasuyuki Shiraishi ◽  
Shun Kohsaka ◽  
Ayumi Goda ◽  
Yosuke Nishihata ◽  
...  
Keyword(s):  
Heart Failure ◽  
Liver Function ◽  
Liver Function Tests ◽  
Abnormal Liver Function ◽  
Adverse Outcomes ◽  
Long Term Outcomes ◽  
Function Tests ◽  
Parameter Values

Abnormal liver function tests (LFTs) are known to be associated with impaired clinical outcomes in heart failure (HF) patients. However, this implication varies with each single LFT panel. We aim to evaluate the long-term outcomes of acute HF (AHF) patients by assessing multiple LFT panels in combination. From a prospective multicenter registry in Japan, 1158 AHF patients who were successfully discharged were analyzed (mean age, 73.9 ± 13.5 years; men, 58%). LFTs (i.e., total bilirubin, aspartate aminotransferase or alanine aminotransferase, and alkaline phosphatase) at discharge were assessed; borderline and abnormal LFTs were defined as 1 and ≥2 parameter values above the normal range, respectively. The primary endpoint was composite of all-cause death or HF readmission. At the time of discharge, 28.7% and 8.6% of patients showed borderline and abnormal LFTs, respectively. There were 196 (16.9%) deaths and 298 (25.7%) HF readmissions during a median 12.4-month follow-up period. The abnormal LFTs group had a significantly higher risk of experiencing the composite outcome (adjusted hazard ratio: 1.51, 95% confidence interval: 1.08–2.12, p = 0.017), whereas the borderline LFTs group was not associated with higher risk of adverse events when referenced to the normal LFTs group. Among AHF patients, the combined elevation of ≥2 LFT panels at discharge was associated with long-term adverse outcomes.

scholarly journals Frequency and Prognostic Significance of Abnormal Liver Function Tests in Patients With Cardiogenic Shock

2017 ◽  
Vol 120 (7) ◽  
pp. 1090-1097 ◽  
Author(s):  
Toni Jäntti ◽  
Tuukka Tarvasmäki ◽  
Veli-Pekka Harjola ◽  
John Parissis ◽  
Kari Pulkki ◽  
...  
Keyword(s):  
Liver Function ◽  
Cardiogenic Shock ◽  
Prognostic Significance ◽  
Liver Function Tests ◽  
Abnormal Liver Function ◽  
Function Tests

Interpretation of Abnormal Liver Function Tests

2014 ◽  
Vol 3 (1) ◽  
pp. e139-e148 ◽  
Author(s):  
Mathew Strasser ◽  
Dushyant Singh
Keyword(s):  
Liver Function ◽  
Liver Function Tests ◽  
Abnormal Liver Function ◽  
Function Tests

scholarly journals Statins and Abnormal Liver Function Tests: Is There a Correlation?

Cureus ◽  
2020 ◽  
Author(s):  
Jibran Ashraf ◽  
M Ali Khan ◽  
Syed Minhaj ◽  
Shahzad Khatti ◽  
Khawaja M Aarij ◽  
...  
Keyword(s):  
Liver Function ◽  
Liver Function Tests ◽  
Abnormal Liver Function ◽  
Function Tests
Sign in / Sign up

Export Citation Format

Share Document